NSE · Other
EPS came in at 7.60 against a street estimate of 8.40 — a miss of 9.5%.
with an average price target of ₹2,328.14.
| Document | Date |
|---|---|
| Investor presentation · Q4 FY26 JB CHEMICALS & PHARMACEUTICALS LIMITED – Q4 FY'26 SUMMARY HEADLINE NUMBERS • Q4 FY'26 Revenue: INR 904 crores, down 5% year-on-year • Q4 EBITDA (adj | 2026-05-13 |
| Annual report FY2026 JB CHEMICALS & PHARMACEUTICALS LIMITED — ANNUAL REPORT 2025-26 HEADLINE NUMBERS • Consolidated Operating Revenue FY26: ₹4,148 crores • Operating EBI | 2026-03-31 |
| Investor presentation · Q3 FY26 J.B. CHEMICALS & PHARMACEUTICALS LIMITED – Q3 FY'26 SUMMARY HEADLINE NUMBERS • Total Revenue: INR 1,065 crore, up 11% year-on-year • Net Profit: INR | 2026-01-21 |
| Investor presentation · Q2 FY26 J.B. CHEMICALS & PHARMACEUTICALS LIMITED Q2 FY '26 EARNINGS CALL SUMMARY --- HEADLINE NUMBERS • Total Revenue Q2 FY '26: INR 1,085 crore, up 8% yea | 2025-11-14 |
| Investor presentation · Q1 FY26 J.B. CHEMICALS & PHARMACEUTICALS LIMITED – Q1 FY26 SUMMARY HEADLINE NUMBERS • Total Revenue: INR 1,094 crore, up 9% YoY • Operating EBITDA (excludin | 2025-08-05 |
| Annual report FY2025 JB CHEMICALS & PHARMACEUTICALS LIMITED – ANNUAL REPORT FY 2024-25 SUMMARY HEADLINE NUMBERS • Total Revenue FY25: ₹3,918 crores, up 12% YoY • Operati | 2025-03-31 |
| Annual report FY2024 JB CHEMICALS & PHARMACEUTICALS LIMITED – ANNUAL REPORT FY2023-24 SUMMARY HEADLINE NUMBERS • Revenue FY24: INR 3,484 crores (19% CAGR over 3 years fr | 2024-03-31 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹9.30 / share ex-date May 29, 2026 | 2026-05-29 |
| Dividend | ₹12.70 / share ex-date Feb 11, 2026 | 2026-02-11 |
| Dividend | ₹7 / share ex-date Jul 30, 2025 | 2025-07-30 |
| Announcement | Date |
|---|---|
| Scheme of Amalgamation announced; trading suspended JB Chemicals & Pharmaceuticals Limited's equity shares will stop trading on the stock exchange effective July 17, 2026 (after market close on July 16, 2026) due to a Scheme of Amalgamation. | 2026-07-13 |
| Record date set for merger/hive-off transaction JB Chemicals & Pharmaceuticals Limited has announced that July 17, 2026 will be the record date for a merger or hive-off (demerger) transaction. A record date is the cutoff date used to dete | 2026-07-07 |
| Scheme of Amalgamation intimation under SEBI Listing Obligations JB Chemicals & Pharmaceuticals Limited has announced a Scheme of Amalgamation under SEBI regulations. An amalgamation is a merger where one company combines with another, pooling their asset | 2026-03-25 |
| Scheme of Amalgamation disclosed under regulatory requirement JB Chemicals & Pharmaceuticals Limited announced a Scheme of Amalgamation under stock exchange regulations. This is a corporate restructuring announcement where the company is merging with o | 2026-03-24 |
| Receipt of order for pharmaceutical products JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Receipt of Order | 2025-12-30 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for JB Chemicals & Pharmaceuticals Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.